Blog

NEW YORK, NY / ACCESS Newswire / September 10, 2025 / The history of economic growth is often told through waves of efficiency. The steam engine extracted more work from coal, electrification powered entire industries, and the microchip condensed computation into silicon. Each of these shifts delivered not just incremental improvement but an economy-wide dividend, where productivity gains fueled investment, competitiveness, and prosperity. Today, a new kind of efficiency is emerging, one rooted not in how fast we can consume but in how effectively we can reuse. It is the age of material efficiency, and SMX (NASDAQ:SMX) is uniquely positioned and able to deliver it.

Material efficiency is more than recycling. It is the ability of countries and companies to recover value from the goods they already use, to prove the authenticity and recycled content of those goods, and to loop them back into the economy with confidence. That capability is not a fringe environmental issue.

It is becoming a macroeconomic driver that delivers cost savings, supply chain resilience, and investor favor. At a time when resource volatility and geopolitical uncertainty increasingly set the terms of trade, material efficiency represents a productivity revolution as profound as energy or data efficiency.

Turning Materials Into Data

SMX promotes this new era by turning materials into data. Its patented molecular markers are embedded directly into plastics, metals, textiles, and natural rubber, giving every item a scannable, tamper-resistant identity tied to a verified digital passport. That link follows goods from origin through use, recycling, and chemical transformation, proving recycled content, authenticity, and chain of custody in real time. The result is enforceable compliance, anti-counterfeiting, and true material efficiency that converts sustainability from promise to measurable value. For companies that adopt it, SMX’s platform creates the most valuable form of proof: proof that their supply chains are both sustainable and secure.

That promise has now moved from concept to infrastructure. In collaboration with Singapore’s national research powerhouse A*STAR, SMX has enabled the world’s first country-backed plastics passport program. This is not a pilot or a corporate initiative confined to a single product line. It is national policy that embeds molecular markers into plastics at the point of production, creating a verifiable passport that accompanies each material through its entire lifecycle. That is made even more powerful by SMX’s Plastic Cycle Token (PCT), a tradable instrument monetizing verified recycled inputs seamlessly across global markets. With Singapore leading the charge, the world is witnessing how material efficiency can be operationalized at scale, and how a nation can leverage it into a first-mover advantage.

The dividend is clear. For companies, being able to prove recycled content and chain of custody creates a compliance premium. Instead of treating regulation as a cost, proof becomes a tradable asset that protects brand equity, unlocks market access, and attracts ESG-oriented capital. For countries, the ability to reduce waste, lower import dependency, and strengthen domestic resource loops creates a resilience dividend. Every ton of plastic that is recovered and reused is one less ton imported, taxed, or lost to incineration. For investors, material efficiency signals an entirely new category of value creation, one that echoes the early days of carbon markets but with far more tangible proof and economic impact.

A Plastics Passport Blueprint

The Singapore model matters not just for its own borders but for what it represents regionally and globally. ASEAN alone generates a plastics market worth more than S$4.2 billion annually, much of it underserved by current recycling frameworks. By demonstrating a system that works, Singapore is providing a playbook for replication across the region and beyond. The architecture is not another set of voluntary pledges but a verified reporting system underpinned by SMX’s molecular technology. That makes it credible, scalable, and investable.

Material efficiency is not charity. It is productivity. Just as energy efficiency lowered costs for manufacturers and data efficiency unleashed the digital economy, material efficiency is poised to reshape the competitiveness of companies and countries. Those that can prove what they recover and reuse will enjoy lower costs, stronger supply resilience, and preferential access to capital. Those who cannot will fall behind. That is the nature of dividends: they reward those who position themselves early and compound over time.

SMX has positioned itself as both the enabler and the architect of this shift. By embedding proof at the molecular level, it is providing the rails on which entire markets can run. Singapore has provided the first national case study of what that looks like in practice. Together, they are demonstrating that material efficiency is not an aspiration but a system that delivers measurable dividends.

The lesson is simple but profound. Material efficiency is not about doing less. It is about getting more from what we already have. That shift redefines the growth equation for companies, investors, and, yes, nations. Singapore may be the first to prove it, but with SMX’s technology, it will not be the last. Those who understand the dividend will seize the advantage. Those who do not will be left paying the cost.

References

• Singapore Statutes Online. Environmental Public Health (Public Cleansing) Regulations – Incineration gate-fee schedule; revised 2024.

• National Environment Agency (NEA). “New Licensing Regime for General Waste Disposal Facilities.” Technical brief & dialogue-session slides; 2024.

• Nasdaq.com. “SMX Announces Planned Launch of World’s First Plastic Cycle Token.” Press release; 2024.

• Yahoo! Finance. “SMX Plastic Cycle Token Is a Functional Market-Driven Solution…” News article; 2024.

• National Environment Agency (NEA). Mandatory Packaging Reporting portal. Accessed 5 August 2025.

• Los Angeles Tribune. “Carbon Credits Had Their Day… Now the SMX Plastic Cycle Token…” Feature article; 2025.

• National Environment Agency (NEA). Refuse Collection Fees for Households. Revised 2024; accessed 5 August 2025.

• National Environment Agency (NEA). Waste & Recycling Statistics 2014 – 2023. Singapore: NEA; 2024.

• Shunpoly.com. “How Much Plastic Is Wasted Each Year in Singapore?” Accessed 5 August 2025.

• National Environment Agency (NEA). Waste-Statistics & Overall Recycling (interactive dashboard). Updated 2024; accessed 5 August 2025.

About SMX

As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company’s fight against abusive and possibly illegal trading tactics against the Company’s stock; successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of gold, steel, rubber and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

EMAIL: info@securitymattersltd.com

SOURCE: SMX (Security Matters) Public Limited

View the original press release on ACCESS Newswire

HOUSTON, TX / ACCESS Newswire / September 10, 2025 / Monkey Island LNG (“MILNG”) announced today the execution of a Memorandum of Understanding (MOU) with an investment-grade International Oil Company (IOC) for the offtake of up to 5.20 million tonnes per annum (MTPA) of liquefied natural gas (LNG). MILNG is developing a 26 MTPA LNG export facility in two phases, with Phase 1 targeting 15.6 MTPA across three trains. This offtake agreement represents the output of MILNG’s entire first LNG train in Phase 1.

While the IOC’s name remains confidential at this stage, the MOU demonstrates a growing commercial demand for MILNG’s TrueCost LNG^™ model featuring a transparent, cost-efficient framework that aligns incentives from gas supplier to LNG buyer.

“Partnering with a company of this caliber highlights the depth of industry confidence in MILNG’s next-generation development strategy. This agreement is an unprecedented milestone,” said Greg Michaels, CEO of MILNG. “Securing an MOU for up to 5.20 MTPA with an investment-grade counterparty not only validates our commercial model but also provides critical momentum as we move toward regulatory approvals and Final Investment Decision (FID). When converted into a Sales and Purchase Agreement, the total revenue of this deal would likely exceed $35 billion.”

The MOU reinforces MILNG’s commercial strategy of building long-term, creditworthy offtake partnerships that support financing and development of its 15.6 MTPA Phase 1 of the project. The agreement also aligns with a broader trend of buyers seeking contract transparency and operational reliability in a dynamic global LNG market. MILNG continues to advance commercial and engineering milestones across the project and is in active discussions with additional offtakers for remaining volumes on Phase 1.

Michaels added, “With regulatory advancements underway, engineering contracts awarded, a long-term supply agreement secured, and now a major offtake agreement, MILNG has positioned itself as a next-generation leader in the global LNG marketplace. With the strong market validation on our differentiated development model, we look forward to playing a key role in the next wave of U.S. LNG exports.”

Key Highlights

• Up to 5.20 MTPA of LNG offtake secured

• Agreement covers output of MILNG’s first liquefaction train

• Total potential revenues exceeds $35 billion when converted to an SPA

• Signals strong market demand for MILNG’s TrueCost LNG^™ model

• Supports progress toward regulatory milestones and FID

About Monkey Island LNG

Monkey Island LNG (“MILNG”) is a private company addressing the global energy crisis and growing demand for LNG through the development of critically needed U.S. natural gas infrastructure. Its flagship project, located on Monkey Island in Cameron Parish, Louisiana, sits just 2 miles inland from the Gulf of Mexico near abundant gas supply and features a proven and stable liquefaction technology of COP, an innovative commercial structure, and a low-cost construction plan leveraging an industry-proven EPC contractor McDermott. For more information, go to www.monkeyislandlng.com.

Press Contacts

For Monkey Island LNG:

Greg Michaels, CEO, Monkey Island LNG
Greg.m@mkyisland.com
949-636-5900

Forward-Looking Statement

This communication contains forward-looking statements within the meaning of applicable securities laws. All statements, other than statements of historical fact, are forward-looking statements and involve risks, uncertainties, and assumptions. These include, without limitation, statements regarding the expected scope, design, and timing of the Monkey Island LNG project; the execution, terms, and timing of definitive agreements; anticipated commercial progress; and other future events or developments.

Although Monkey Island LNG (“MILNG”) believes the expectations expressed in such forward-looking statements are reasonable, there can be no assurance that they will prove correct. Forward-looking statements are based on current assumptions and are subject to a number of risks and uncertainties, many of which are beyond our control. These risks include, but are not limited to: changes in market conditions, credit and capital markets, and industry norms; failure to successfully execute or complete contracts; changes in project scope, design, or schedules; availability of qualified personnel and resources; contract modifications, cancellations, or disputes; and other factors that could cause actual results to differ materially from those expressed or implied.

Forward-looking statements speak only as of the date of this communication. MILNG undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances after the date hereof, except as required by applicable law. Readers are cautioned not to place undue reliance on forward-looking statements.

SOURCE: Monkey Island LNG

View the original press release on ACCESS Newswire

– Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients –

– Gemini could potentially revolutionize the treatment of acute and chronic inflammatory disease –

Data discussion webcast/conference call will be held at 8:30 am Eastern Time

SAN DIEGO, CA / ACCESS Newswire / September 10, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company focused on rebalancing inflammation, will host a corporate update webcast/conference call (details below) at 8:30 am Eastern Time to review groundbreaking activity data from its Phase 1b PRIME clinical study in stage 3 and 4 chronic kidney disease (CKD) patients. The primary endpoint to evaluate the safety and tolerability of escalating doses of Gemini was met.

More importantly, Gemini significantly reduced inflammatory activity and restored normal cellular response to stimuli as measured in peripheral blood mononuclear cells (PBMCs) isolated from patients at predose, 2, 24, and 168 hours post-dose, demonstrating Gemini’s ability to durably rebalance the inflammatory process at the cellular level.

“The activity observed with a single dose of Gemini in patients is shocking,” said Principal Investigator Adam Horeish, MD, Balboa Research. “This effect suggests a meaningful step forward in addressing the underlying immune dysregulation observed in patients with chronic kidney disease, and I am intrigued by the potential of Gemini to treat multiple types of acute and chronic inflammation.”

“The results from this Phase 1b study represent a possible breakthrough in the treatment of inflammation,” said Principal Investigator Pablo Pergola, MD, PhD,Research Director at Clinical Advancement Center, PLLC. “By addressing the inflammatory component of CKD, we may be able to improve patient outcomes and bring meaningful benefit to those living with this challenging condition. We look forward to working with the Revelation team to advance Gemini as a potential treatment for CKD.”

“The clear results from the PRIME study demonstrate the power of Gemini to elicit trained immunity,” said Julia K. Bohannon, Ph.D., Associate Professor, Department of Anesthesiology, Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center. “It is highly validating to see results consistent with the findings from our animal studies, as I would have expected. The strength of the effect of a single dose reinforces my confidence in the potential of Gemini as a promising treatment for burn patients.”

The PRIME study enrolled 40 patients from 32 to 78 years of age, at 3 US clinics located in San Diego and San Antonio, specializing in the care of patients with CKD. A total of 5 cohorts (8 patients per cohort, 6 treated/2 placebo) at 4 dose levels were enrolled: a subtherapeutic dose, a low dose, the target dose (cohorts 3 and 4), and a high dose – an extension protocol was conducted to collect additional PBMC and biomarker samples in 8 Gemini naive or secondary naive patients. The primary endpoint was evaluation of safety.

In addition to safety measures, patient PBMCs were isolated predose and at 2, 24, and 168 hours post-dose. PBMCs were analyzed ex vivo for background inflammation by measurement of IL-1β, TNF-α, IL-6, IL-10, and IL-1RA. Cells were also assessed for response to stimulation by lipopolysaccharide (LPS, also known as endotoxin) or high mobility group box-1 protein (HMGB1). Subgroup analysis divided patients into two categories, those with PBMCs of minimal background inflammation activity (£40 pg/mL IL-1β) and normal response to stimuli, and those with significant background inflammation activity (>40 pg/mL IL-1β) and no response to stimuli. Approximately 50% of patients were in each group.

In patients with high background PBMC activity, Gemini significantly reduced inflammation relative to placebo patient PBMCs post dose (IL-1β: p0.01; TNF-α: p=0.05; IL-6: p0.01; IL-10: p0.01; IL-1RA: p0.001) and remained significantly below their baseline value through 7 days. Background inflammation was reduced to levels comparable to PBMCs isolated from healthy subjects.

Additionally, Gemini was able to demonstrate correction of the immunoparalysis typical to chronic disease. Gemini significantly increased the responsiveness to LPS stimulation in high background patient PBMCs relative to placebo at all timepoints (IL-1β: p0.0001; TNF-α: p0.002; IL-6: p0.0002; IL-10: p=0.09; IL-1RA: p0.01). Gemini also significantly increased the responsiveness of patient PBMCs with high background vs placebo patient PBMCs with high background at all time-points to HMGB1 stimulation (IL-1β: p0.05; TNF-α: p0.01; IL-6: p0.01; IL-10: p0.05; IL-1RA: p0.002). The increased responsiveness was comparable to PBMCs isolated from healthy subjects. These results show the ability of Gemini to restore normal cell function, even as far as one week after a single dose.

For the low background patients, as expected, Gemini does not increase inflammatory activity. Additional analysis on the effect of LPS or HMGB-1 stimulation is ongoing.

Gemini administration was well-tolerated at the target dose (established as the maximum tolerated dose in healthy volunteers) with all events reported as mild (Grade I). Adverse events observed at the target dose included transient headache, chills, loose stool, and body aches. Three adverse events at the highest dose (above the target dose) were reported as severe (Grade III), and included chills, nausea and vomiting, all resolving in 3 hours or less. Other reported events were either mild (Grade I) or moderate (Grade II). All events corresponded with the previous healthy volunteer study, as well as with preclinical findings, and are consistent with the expected pharmacology of the drug. No serious adverse events were reported. Gemini administration did not result in clinically significant trends in clinical safety blood or urinalysis parameters (aside from expected immune cell mobilization). There were no clinically significant changes or trends in vital sign parameters or ECG assessments following administration of Gemini.

“The results of the PRIME study demonstrate the potential of Gemini to be a game-changer in the treatment of acute and chronic inflammation,” said James Rolke, Chief Executive Officer of Revelation. “We look forward to our scheduled End of Phase 1 meeting with the FDA later this year to discuss the advancement of this exciting program.”

The webcast at 8:30 am Eastern Time can be accessed https://www.webcaster4.com/Webcast/Page/3139/52906, or to call in, please dial 888-506-0062 (toll free in the US), +1 973-528-0011 (if International) and use participant access code 289672. A copy of the slides being presented in the webcast can be found on Revelation’s website https://www.revbiosciences.com/s/925P1bData.pdf.

Revelation will seek to publish these results and those from ongoing additional data analysis. For more information, please visit www.RevBiosciences.com.

About CKD

Chronic kidney disease is a pervasive problem in the United States and world-wide. CKD is due to chronic inflammation and can be initiated and propagated in several ways. One prevalent condition is the high blood sugar levels associated with diabetes (either Type 1 or Type 2). High blood sugar is toxic to kidney cells creating stress which imitates the inflammatory process leading to the demise of these cells with subsequent fibrosis, ultimately resulting in continuous loss of kidney function over time. High arterial blood pressure is another source of stress that initiates the inflammatory process leading to CKD. Other risk factors include heart disease, obesity, family history of CKD, or advanced age. Progression of chronic kidney damage often leads to end stage renal disease with the need for renal replacement therapy (dialysis or transplantation), resulting in significant morbidity and mortality for affected patients. Kidney disease is a leading cause of death in the United States.

About Gemini

Gemini is the Company’s proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD^®), a toll-like receptor 4 (TLR4) agonist. TLR4 stimulation with Gemini rebalances the innate immune response. Gemini is being developed as a treatment and a prevention of acute and chronic diseases associated with dysregulated inflammation.

About Revelation Biosciences, Inc.

Revelation Biosciences, Inc. is a clinical stage life sciences company focused on rebalancing inflammation using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for post-surgical infection, as prevention for acute kidney injury and for the treatment of chronic kidney disease.

For more information, please visit www.RevBiosciences.com.

Forward-Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These forward-looking statements are generally identified by the words “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions. We caution investors that forward-looking statements are based on management’s expectations and are only predictions or statements of current expectations and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from those anticipated by the forward-looking statements. Revelation cautions readers not to place undue reliance on any such forward looking statements, which speak only as of the date they were made. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: the ability of Revelation to meet its financial and strategic goals, due to, among other things, competition; the ability of Revelation to grow and manage growth profitability and retain its key employees; the possibility that the Revelation may be adversely affected by other economic, business, and/or competitive factors; risks relating to the successful development of Revelation’s product candidates; the ability to successfully complete planned clinical studies of its product candidates; the risk that we may not fully enroll our clinical studies or enrollment will take longer than expected; risks relating to the occurrence of adverse safety events and/or unexpected concerns that may arise from data or analysis from our clinical studies; changes in applicable laws or regulations; expected initiation of the clinical studies, the timing of clinical data; the outcome of the clinical data, including whether the results of such study is positive or whether it can be replicated; the outcome of data collected, including whether the results of such data and/or correlation can be replicated; the timing, costs, conduct and outcome of our other clinical studies; the anticipated treatment of future clinical data by the FDA, the EMA or other regulatory authorities, including whether such data will be sufficient for approval; the success of future development activities for its product candidates; potential indications for which product candidates may be developed; the ability of Revelation to maintain the listing of its securities on NASDAQ; the expected duration over which Revelation’s balances will fund its operations; and other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the SEC by Revelation.

Company Contact

Mike Porter
Investor Relations
Porter LaVay & Rose Inc.
Email: mike@plrinvest.com

Chester Zygmont, III
Chief Financial Officer
Revelation Biosciences Inc.
Email: czygmont@revbiosciences.com

SOURCE: Revelation Biosciences, Inc.

View the original press release on ACCESS Newswire

MONTREAL, QC / ACCESS Newswire / September 10, 2025 / Vision Marine Technologies Inc. (NASDAQ:VMAR) (“Vision Marine” or the “Company”), a pioneer in electric marine propulsion with an award-winning retail network, Nautical Ventures, today announced the advancement of its Electric Representative Training Program across Nautical Ventures’ Florida dealership network.

The program has completed its first phase with the selection and training of Electric Representatives at strategic locations. Customers visiting Nautical Ventures showrooms now receive informed guidance on Vision Marine’s proprietary E-Motion^™ 180E, the industry’s first certified 180 HP continuous electric outboard, engineered for performance, reliability, and seamless integration across multiple boat platforms. Vision Marine has already delivered two E-Motion^™ 180E-equipped boats to customers and finalized additional integrations scheduled for delivery in the coming month. These initial deliveries demonstrate that production is active and that Vision Marine is already placing boats into customer hands, while preparing dealerships to guide and support adoption as more integrations follow.

The next phase of the program expands into on-water training sessions, giving sales staff hands-on rundowns of electric powertrain operation and performance. In the coming weeks, E-Motion^™ 180E-equipped boats will also be made available for demonstrations, ensuring teams can share firsthand experience with prospective customers. The program highlights the advantages of Vision Marine’s electric powertrain, including significant noise reduction, the absence of gasoline fumes, reduced maintenance requirements, and strong torque delivery compared to internal combustion engines.

“Education is essential for adoption,” said Alexandre Mongeon, CEO of Vision Marine. “By combining structured training with real-world demonstrations, we ensure our teams are confident in presenting the full potential of E-Motion^™ technology, from its unmatched 180 HP continuous output to its proven integration across boat models. At the same time, our recent deliveries highlight that production is commercial boats are being delivered and enjoyed on the water.”

Nautical Ventures Group now has multiple Vision electric boats in stock at its east and west coast showrooms, available for immediate delivery. This rollout underscores Vision Marine’s broader strategy of integrating electric propulsion responsibly within an award-winning retail network, while anchoring adoption on the Company’s industrialized E-Motion^™ 180E platform.

About Vision Marine Technologies Inc.

Vision Marine Technologies Inc. (NASDAQ:VMAR) is a disruptive marine company offering premium boating experiences across both electric and internal combustion segments. Through its E-Motion^™ high-voltage technology and Nautical Ventures’ nine-location retail and service network in Florida, Vision Marine unites proprietary engineering with direct-to-consumer sales, after-sales support, and integration services.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Factors that could cause such differences include, among others, market conditions, customer adoption, operational execution, and regulatory developments. Vision Marine undertakes no obligation to update forward-looking statements except as required by law.

Investor Relations Contact:

Bruce Nurse
Vision Marine Technologies Inc.
(303) 919-2913
bn@v-mti.com

SOURCE: Vision Marine Technologies Inc

View the original press release on ACCESS Newswire

Maxon One unifies Cinema 4D, ZBrush, Redshift, and Red Giant in bold ecosystem redesign, with tons of new feature capabilities across VFX, 3D modeling, and motion graphics solutions.

BAD HOMBURG, GERMANY / ACCESS Newswire / September 10, 2025 / Maxon today unveiled the latest Maxon One release, delivering new innovations across its unified creative ecosystem and introducing a fresh visual identity that is modular, cohesive, and connected. Designed to empower artists at every skill level, from students to seasoned industry veterans, the Fall release streamlines workflows, removes technical barriers, and delivers cutting-edge creative possibilities across VFX, motion graphics, 3D modeling, sculpting, rendering, editing, and more.

From cinematic storytelling to broadcast graphics, gaming design to architectural visualization, creators across the full spectrum of disciplines rely on Maxon One for its deeply integrated tools. Cinema 4D now has GPU-accelerated art-directable simulations, while Maxon Studio streamlines video and broadcast design with Red Giant effects and customizable templates, enhanced with embedded assets and reusable Capsules. Redshift pushes architectural rendering to new heights with procedural clouds, refined realism, and faster interactive displacement, while ZBrush brings professional-grade sculpting to iPad with 3D printing support and powerful pipeline integration. This release expands on the power of Maxon’s capabilities, all within a unified platform that moves ideas seamlessly from concept to final render.

“Maxon One is the creative backbone for artists across industries and at all skill levels,” said David McGavran, CEO of Maxon. “This release builds on the features creators already love while introducing innovations that remove technical barriers and open new creative possibilities. Whether you’re in the classroom or at the helm of a major production, Maxon One helps you create without limits.”

A Unified Ecosystem for Every Stage of Creation

The Maxon ecosystem is built on innovations that empower creative freedom, from the portability and precision of ZBrush on iPad to the immersive visual fidelity and cinematic quality of Redshift rendering. Maxon One unifies Cinema 4D, ZBrush, Redshift, Red Giant, and Maxon Studio in a deeply integrated platform designed to work harmoniously from one stage of creation to the next. With compatibility across industry-leading tools such as Adobe Creative Cloud and Blackmagic Design, creators can build, animate, render, and finish their projects without friction.

New Maxon Capabilities Across Every Creative Discipline

For animators and motion graphics designers, Cinema 4D enables fast, unified simulations that are easy to create and art-direct. All the procedural power of C4D integrates seamlessly with rigid-body, soft-body, cloth, pyro, particles, and now liquids. The new AI search, which operates entirely on your local machine, makes finding Capsules, assets, textures, and presets effortless, with faster and more precise results ready in an instant.

For game developers and virtual production teams, the latest Cineware for Unreal Engine streamlines asset, lighting, and material workflows, reducing rework and accelerating iteration. Support for Cinema 4D modifiers, enhanced texture tag controls, and automatic material instance creation keep scenes accurate and flexible from import to final output, empowering teams to focus on worldbuilding, not pipeline roadblocks.

For sculptors and 3D modelers, ZBrush adds creative freedom on desktop and iPad. Python scripting, available on desktop, unlocks automation and deeper pipeline integration, while 3D printing tools bring full desktop parity to the iPad. Surface Noise also sees an upgrade with a refreshed UI, per-noise resets, alpha transforms, and full undo/redo support, giving artists greater control over detail. ZBrush for iPad UI enhancements let users move the bottom bar, adjust the modifier wheel, and save or share custom interfaces for a personalized setup. Artists can rapidly sculpt, customize, and export designs for collectibles, props, and prototypes, with upcoming UV editing and hard-surface modeling updates extending its versatility.

For VFX artists, Redshift introduces new tools for photorealistic and stylized environments with greater realism and speed. Texture Displacement delivers faster, interactive previews with minimal subdivision; Scene Units ensure materials match real-world scale; and the new Procedural Clouds and Sun & Sky system make it effortless to add atmospheric depth to any scene. Artists can render more accurate, visually rich worlds in less time, whether for film, advertising, or immersive media.

For editors and colorists, Maxon Studio now supports embedded assets and reusable Capsules, making it possible to build once and use anywhere. This means more customization, faster setup, simple scaling, and consistent brand visuals, all without leaving the creative environment.

“For my new film ‘SKETCH’ (out now in theaters!), we sculpted creatures in ZBrush, animated in Cinema 4D, rendered in Redshift, and polished with Red Giant, all without ever feeling like we were duct-taping workflows together. Every production throws curveballs, but knowing exactly how I could ‘fix it in post’ with Maxon tools eliminated many of the usual roadblocks that inevitably come up when you’re creating 11+ monsters made out of glitter, chalk and crayons,” said Seth Worley, Director of “SKETCH” (read more about how Seth and team brought the film’s monsters and effects to life). “I think I can say definitively that, without Maxon One, we would still be finishing the movie.”

Trusted by the World’s Leading Creatives
Maxon One powers work for leading artists and studios worldwide, producing content that captivates audiences across every medium. From blockbuster films and award-winning streaming series to AAA games and global ad campaigns, Maxon’s tools deliver quality, efficiency, and creative freedom. Recent projects include:

• Godzilla Minus One: Director Takashi Yamazaki and Modeler Kousuke Taguchi used ZBrush to reimagine the iconic monster, utilizing Redshift for rendering with speed and high-fidelity.

• Shōgun: Winning 2024 Creative Arts Emmy® Award for Outstanding Main Title Design, design studio Elastic brought the Shōgun title sequence to life entirely in Cinema 4D, with key props like the samurai helmet meticulously crafted in ZBrush to match existing assets from the show.

• God of War: Ragnarök: U.K.-based freelance creature designer and digital sculptor Luke Starkie used ZBrush to sculpt creatures, including one of the most memorable bosses for PlayStation’s flagship title.

• Tuft & Needle: ManvsMachine relied on Cinema 4D and Redshift to help retailer Tuft & Needle visualize what it takes to create the elements of a perfect night’s sleep.

Committed to the Next Generation: Dream It. Make it.

Every great artist starts with curiosity and a spark of imagination. That’s why Maxon is making it easier than ever for students, hobbyists, and emerging creators to jump in and start creating. From free tutorials and global community events to affordable student licenses for the same tools used on blockbuster films and AAA games, Maxon gives creators everything they need to learn, experiment, and grow. Whether you’re crafting your first 3D scene, sculpting characters on an iPad, or exploring motion graphics for social content, Maxon is here to help artists turn ideas into something amazing.

Experience Maxon One at IBC2025

Attendees can experience the new Maxon One release and its reimagined ecosystem at IBC2025, RAI Amsterdam, September 12-15. Visit Booth 7.B45 to see live demos of procedural animation in Cinema 4D, real-time rendering in Redshift, mobile sculpting in ZBrush, and streamlined design-to-delivery workflows in Red Giant and Maxon Studio.

Book a meeting or training session with Maxon experts to learn more about Maxon One, or a specialized training session with experts to learn more about:

• Cinema 4D

• Red Giant

• Redshift

• ZBrush

About Maxon

Maxon is a developer of high-quality, professional creative tools that empower artists to bring stunning visuals to life. From 3D modeling and animation to impeccable rendering and cinematic effects, the Maxon One ecosystem provides a comprehensive suite of industry-leading solutions. At Maxon, we are committed to fueling creative freedom, fostering a thriving artistic community, and being the driving force behind bold, iconic content.

Media Contact

Megan Fasy
Grithaus Agency
(e) megan@grithaus.agency
(p) +1 (617) 480-3674

###

SOURCE: Maxon Computers

View the original press release on ACCESS Newswire

NEW YORK, NY / ACCESS Newswire / September 10, 2025 / Big Interview, the leader in AI-powered job training and interview coaching, today announced the launch of PracticeAI, a breakthrough AI interview practice tool that redefines how candidates prepare for interviews.

Designed to replicate the unpredictability and pressure of real-world interviews, PracticeAI delivers a conversational, voice-to-voice experience that adapts in real time to each user’s responses. By drawing on resumes and job descriptions, the tool generates tailored questions and probing follow-ups. It mirrors the priorities and style of actual hiring managers.

“With PracticeAI, we’re introducing a truly new experience in interview preparation,” said Alex Andrei, CEO of Big Interview. “The AI doesn’t just ask pre-written questions; it listens, adapts, and challenges you the way a real interviewer would. The result is practice that feels authentic, dynamic, and deeply personalized.”

A Game-Changer in Interview Preparation

Unlike traditional mock interview tools, PracticeAI evolves dynamically throughout each session. Every response prompts the AI to build deeper, context-aware questions. This pushes candidates to think on their feet and refine their storytelling.

After each practice session, users receive feedback in three critical categories:

• Alignment with the role – Were answers tailored to what the company is looking for?

• Clarity – Did responses come across as clear, structured, and persuasive?

• Confidence – Did the candidate sound composed and in control?

“At Big Interview, our mission is to help job seekers find opportunities faster and with more confidence,” said Pamela Skillings, Co-founder and Chief Coach at Big Interview. “PracticeAI gives people a safe space to build those skills. By practicing with questions that change in the moment and feedback that reflects real hiring priorities, job seekers can walk into interviews prepared for whatever comes their way.”

Early Feedback from Beta Users

Initial testers describe PracticeAI as seamless, tailored, and confidence-building:

• “I liked the quick responses to my answers-it made it feel seamless and like an interview with an actual person.”

• “Enjoyed interacting with the voice, simple user interface, relevant commentary on my answers in the moment.”

• “I loved that the questions were tailored to my resume and the job description.”

• “What I found most valuable was the level of feedback given on the answers to each question… it focused on both strengths and areas of improvement.”

• “As a professor, I imagine students will be conducting job interviews with AI assistants pretty regularly, sort of the way video screening interviews became standard practice in the 2010s.”

Supporting Students and Job Seekers Everywhere

For colleges, universities, and workforce development agencies, PracticeAI offers a scalable, research-based solution to build career readiness at every level. By helping candidates reduce job search time and perform better in high-stakes interviews, PracticeAI supports institutions in their mission to prepare students and job seekers for meaningful employment outcomes.

“Technology is transforming how hiring happens,” Skillings added. “PracticeAI ensures that learners aren’t just prepared for that shift, they’re ahead of it.”

Availability

Institutions and workforce organizations can learn more about integrating PracticeAI into their career readiness programs by visiting www.biginterview.com/get-practice-ai.

About Big Interview:
Big Interview is an industry-leading online platform designed to help job seekers of all backgrounds build confidence and master their interview skills. Combining expert video lessons with AI-driven interview practice, Big Interview provides users with personalized feedback, real-time coaching, and tailored training for various industries and experience levels. Big Interview is used by 700+ non-profits, workforce agencies, Fortune 500 companies, universities, and government organizations to help job seekers secure employment 5X faster than the national average.

SOURCE: Big Interview

Related Images

View the original press release on ACCESS Newswire

Voices announces the availability of its one-of-a-kind, ethically sourced character, high quality voice dataset, featuring over 450 distinct character types, each performed by professional voice contributors.

NEW YORK CITY, NEW YORK / ACCESS Newswire / September 10, 2025 / Voices, the world’s leading voice solutions and voice data provider, today announced the release of its new character audio dataset featuring character-specific voice data, purpose-built for voice AI training.

The dataset offers a large and expressive range of voice data, featuring 19 tones, 35 emotions, and 21 paralinguistic cues across more than 450 character types, ranging from a 1920s Flapper, a Drill Sergeant, a Wise Old Wizard, and more. Developed in collaboration with trained, professional voice talent-with each contributor recording scripts in multiple characters and tones-it stands as the world’s only multi-character dataset of its kind, available for AI training.

“Voice data is both scarce and in high demand. The base models powering voice AI today simply cannot deliver authentic sounding, tailored experiences. The best voice AI models will be built on curated and ethically sourced character data, which is exactly what we have launched today,” says Dheeraj Jalali, Chief Technology Officer at Voices. “Voices has a long legacy of working with professional voice talent. Given that history, we are uniquely positioned to connect trained contributors with emerging AI applications, and as the industry grows, we see even more opportunities for voice talent to help meet the market demand.”

Voices character datasets are delivered in a ready-to-use format, allowing researchers and developers to instantly ingest files and begin training. Each audio file is accompanied by rich metadata-tagged by character, text, tone, and emotion-and fully transcribed to train AI models at scale with more natural, nuanced results.

All audio recordings were collected using Voices’ patent-pending, in-house, virtual Recording Studio. The recording process includes auto-directed sessions to ensure the highest-quality audio and authentic performances and expressions needed for advanced AI training.

Voices is committed to the ethical development of voice AI. Voices works with the best voice talent in the world, and has cultivated long-standing relationships built on trust. All data is sourced with transparent terms and conditions, providing contributing talent with control, consent, and fair compensation.

Those interested in learning more about Voices’ voice data offerings can visit: https://www.voices.com/landing/character-datasets.

About Voices

Voices is the world’s leading enterprise-class marketplace and platform to ethically source voice over actors, voice AI, and voice data to train AI models. For more than two decades, the world’s biggest brands, like Shopify, Microsoft, and Cisco, have trusted Voices to ‘find their voice’. The Voices talent base is composed of many millions of actors across the globe, who trust Voices to support their interests and help them find meaningful work.

Media Contact: Patrice Aldave | patrice.aldave@voices.com | 519-858-4224

SOURCE: Voices

View the original press release on ACCESS Newswire

With Star Talent, Fresh Perspectives and Expanded Coverage, PHLY Cements Itself as the Number One Destination for Diehard Eagles Fans

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / September 10, 2025 / PHLY, the fastest-growing sports media platform in Philadelphia, announced today the launch of Eagles legend Brandon Graham’s new weekly show “Brandon Graham Unblocked,” debuting at 11 a.m. ET. The show, co-hosted by PHLY’s Bo Wulf, marks Graham’s first podcast following his NFL retirement and gives fans insider access to his perspective on the team and the season ahead.

“Brandon Graham Unblocked” headlines PHLY’s expanded Eagles lineup for 2025, underscoring the network’s position as the number one destination for diehard Eagles fans. PHLY is also bringing back “Exciting Mics” for a second season, hosted by Eagles players Cooper DeJean and Reed Blankenship, delivering weekly episodes throughout the NFL season. After a breakout first season with more than 1.8 million views and downloads and consistent top rankings among football podcasts, the duo returns with fresh stories, on-field insight, and the chemistry fans loved.

Former Eagles star WR DeSean Jackson will also debut a new weekly podcast the week of Sept. 22, centered on his journey as Delaware State University’s head coach and his unique vantage point on the NFL and the Eagles. PHLY also recently announced that veteran reporter EJ Smith has joined as its lead Eagles insider, further strengthening PHLY’s reporting and on-the-ground coverage.

“With Brandon Graham, DeSean Jackson, and the return of Exciting Mics, PHLY now combines unmatched star power with the daily, authentic coverage our fans crave,” said Brandon Spano, CEO of ALLCITY Network. “We’re proud to deliver the most complete, talent-driven Eagles coverage for fans in Philadelphia and beyond. This lineup is a major step forward for our business, our community, and the advertisers who partner with us.”

“I’m excited to bring fans inside the game and share my journey in a whole new way,” said Graham. “This show is about connecting with Eagles fans and having fun together all season long.”

The PHLY weekly lineup for Eagles coverage this fall will include:

Mondays

• PHLY Eagles – Bo Wulf, EJ Smith, Fran Duffy

• The Anthony Gargano Show

Tuesdays

• PHLY Eagles – Bo Wulf, EJ Smith

• The Anthony Gargano Show

Wednesdays

• PHLY Eagles – Jamie Lynch, Rich Hoffman

• Brandon Graham Unblocked

• The Anthony Gargano Show

Thursdays

• PHLY Eagles – Bo Wulf, EJ Smith, Fran Duffy

• Exciting Mics – Cooper Dejean, Reed Blankenship, Special Guests

• Desean Jackson Show

• The Anthony Gargano Show

Fridays

• PHLY Eagles – Bo Wulf, EJ Smith, Deniz Selman

• The Anthony Gargano Show

Sundays (Gameday)

• PHLY Eagles Pregame Show

• PHLY Eagles Postgame Show – Bo Wulf, Fran Duffy, Vinny Curry

This expanded lineup brings fans more than 15 hours of Eagles programming weekly, complemented by original written content, social engagement, and live community experiences. For advertisers, PHLY offers a direct line to the most loyal and engaged Eagles audience in Philadelphia.

Fans can catch “Brandon Graham Unblocked” every Wednesday on YouTube, Apple Podcasts, Spotify, and PHLY’s digital platforms. “Exciting Mics” can be found on YouTube, Spotify Video or wherever fans consume podcasts, and The Desean Jackson Show debuts Thursdays on PHLY Sports YouTube.

About ALLCITY Network

ALLCITY Network is reimagining local sports coverage, delivering daily, team-specific shows available across streaming video, podcast, social, and other digital platforms. Launched in 2019 in Denver, ALLCITY has since expanded to Phoenix, Chicago, Philadelphia, and Dallas, with a portfolio of 35+ daily and weekly shows across the country. Collectively, ALLCITY’s channels provide over 7,500 hours of live sports content annually, complemented by local sports news, analysis, and community-driven programming. Beyond media products, ALLCITY connects with fans through Diehard Memberships, original custom apparel lines and community-driven events, such as tailgates and watch parties. For more information about ALLCITY Network, visit www.allcitynetwork.com and allphly.com.

MEDIA CONTACT
ALLCITY Network // PHLY
press@allcitynetwork.com

SOURCE: ALLCITY Network

View the original press release on ACCESS Newswire

SAN BERNARDINO COUNTY, CA / ACCESS Newswire / September 10, 2025 / Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF) (Dateline or the Company), a North American-focused mining and exploration company, is pleased to announce that it has commenced a major drilling campaign at its 100%-owned Colosseum Gold-REE Project in San Bernardino County, California.

Highlights

• Drilling Underway – Drilling has commenced this week at the 100%-owned Colosseum Gold-REE Project in California.

• Expanded Drill Fleet – Major Drilling has been contracted to provide a high-powered, fast reverse circulation (RC) rig, supplementing Dateline’s fleet of three company-owned drill rigs (two currently on site) and significantly boosting drilling speed and capacity.

• Large-Scale Campaign – The total drilling program is expected to exceed 10,000 metres of combined RC and diamond drilling, with activities anticipated to continue through the remainder of 2025.

• New Gold & REE Targets -Recently identified magneto-telluric (MT) generated gold and rare earth element targets are being refined and will be progressively incorporated into the drilling plan. These include multiple high-priority gold targets (breccia pipe anomalies) and deep REE targets identified by geophysical surveys.

• Geotechnical Program – A dedicated geotechnical drilling program is underway in parallel, gathering critical data to inform mine planning and support BFS-level engineering studies.

• Accelerating BFS – The program will accelerate the Colosseum BFS, with drilling data to support mine design and resource upgrades aimed at expediting the timeline to first gold production.

Drilling started this week and will include extensional gold drilling around the existing 1.1 Moz gold resource, as well as testing new regional targets. This campaign represents a pivotal step in advancing the Bankable Feasibility Study (BFS) and is aimed at accelerating Colosseum’s development toward near-term gold production.

To maximise efficiency and drilling throughput, Dateline is augmenting its on-site drill fleet. While the Company currently has two owned drill rigs at Colosseum, it has opted to deploy one of its own diamond drill rigs and supplement it with a high-performance reverse circulation (RC) rig provided by Major Drilling, the world’s leading provider of specialized drilling services in the metals and mining industry.

The contracted RC rig is being mobilised to site in the next 1-2 weeks and offers faster drilling rates, allowing the Company to rapidly progress both mineral resource-definition drilling and exploration of new targets in tandem. In addition to mineral resource drilling, a geotechnical drilling program has commenced, which will collect essential data on rock stability and ground conditions to feed into mine design and planning for the BFS.

The drilling plan will also progressively test several new exploration targets for gold and rare earths. These targets have been generated from recent exploration datasets, including a 3D magneto-telluric (MT) geophysical survey and detailed geochemical and mapping programs. Notably, the Company has identified six high-priority gold target areas (interpreted as potential breccia pipe structures) exhibiting similar geophysical signatures to the known gold-bearing pipes at Colosseum.

Additionally, multiple deep-seated resistivity anomalies pointing to possible carbonatite-hosted REE mineralisation (analogous to the nearby Mountain Pass mine) have been delineated. Ongoing analysis of the MT and geochemical results is refining these targets, which will be added to the drill schedule as they are confirmed and ranked. By pursuing gold and REE exploration in parallel, Dateline aims to unlock Colosseum’s dual commodity potential efficiently and enhance the project’s overall economics.

The total drilling program is expected to exceed 10,000 metres of RC and diamond drilling. This extensive campaign, one of the largest undertaken at Colosseum, is scheduled to run through at least the end of 2025. Drilling results will be reported as they become available and will feed directly into the Colosseum BFS workstreams, including a potential updated Mineral Resource estimate and open-pit mine designs.

Dateline’s Managing Director, Stephen Baghdadi, commented:

“This is an exciting phase for Dateline as we kick off a major drill program at Colosseum, which is instrumental in accelerating our feasibility study and bringing us closer to production. By utilizing our in-house diamond rig alongside Major Drilling’s high-powered RC rig, we can significantly increase the pace and scope of drilling, allowing us to tackle mineral resource infill, extensional drilling, and new target testing all at once.

“The ability to drill more metres faster will fast-track the Colosseum BFS and shorten the timeline to first gold production. We’re also eager to drill the newly identified gold and rare earth targets, which have the potential to add substantial value.“

Figure 1: Plan view of Colosseum with areas to initially be targeted in the drilling program

Figure 2: Diamond drilling underway at Colosseum

About Dateline Resources Limited

Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF) is an Australian publicly listed company focused on high-value mining and exploration in North America. Its flagship Colosseum Gold-REE Project in California’s Walker Lane Trend combines a proven gold resource with emerging rare earth potential, positioning Dateline as a leader in critical minerals and precious metals.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of applicable securities laws. These statements relate to future events or performance, including the potential of the Colosseum Project, the benefits of U.S. government support, the company’s plans for future development, and the strategic importance of the project for U.S. critical minerals supply. Forward-looking statements are based on current expectations, estimates, and projections and are subject to risks and uncertainties that could cause actual results to differ materially. These risks include fluctuations in gold and rare earth element prices, changes in regulatory or permitting processes, geological or technical challenges, market conditions affecting capital raising, environmental or social factors, and risks related to securing government funding. Dateline Resources cautions readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The company undertakes no obligation to update or revise these statements, except as required by law.

Contact Information

Stephen Baghdadi
Managing Director
Dateline Resources Limited
+61 2 9375 2353
info@datelineresources.com.au
www.datelineresources.com.au

Andrew Rowell
Corporate & Investor Relations Manager
a.rowell@dtraux.com
+61 400 466 226

Follow Dateline on social media:

X: @Dateline_DTR
Truth Social: @dateline_resources
LinkedIn: dateline-resources

This press release is authorized for release by the Board of Dateline Resources Limited.

SOURCE: Dateline Resources Limited

View the original press release on ACCESS Newswire

CALGARY, ALBERTA / ACCESS Newswire / September 10, 2025 / Calgary Integrative Medicine, a leading provider of holistic healthcare in the city, has been honoured with the 2025 Consumer Choice Award in the naturopathic medicine category for Southern Alberta. This recognition marks the clinic’s sixth consecutive year as a recipient, underscoring its commitment to delivering exceptional, patient-centred care.

Since opening in 2017, Calgary Integrative Medicine has established itself as a trusted destination for individuals seeking natural solutions to their health concerns. The clinic is known for its personalised approach to care, tailoring treatments to the specific needs of each patient. With a focus on chronic disease, digestive health, pain management, healthy ageing, and cancer care support, its naturopathic doctors combine traditional practices with innovative therapies to help patients restore balance and improve quality of life.

Comprehensive Services That Support Healing

The clinic offers a wide range of therapies designed to support the body’s natural ability to heal. Patients can access IV nutritional therapy, acupuncture, and herbal remedies, as well as lifestyle and nutritional counselling. These services are complemented by advanced options such as cancer care support, injection therapies, and manual osteopathy, ensuring that each treatment plan is evidence-informed and results-focused.

“Our philosophy is simple,” says Dr. Greg Sikorski, B.Sc., N.D., Clinic Owner. “We believe every patient deserves care that is tailored to them. By combining the latest in natural therapies with specialised services such as cancer care support and injection therapies, we empower people to take control of their health and feel their best.”

This blend of natural treatments and advanced therapies has made the clinic a go-to destination for individuals looking for long-term solutions to health challenges rather than temporary fixes. Whether managing a chronic condition or pursuing preventative care, patients find comprehensive support in a welcoming, patient-first environment.

A Celebration of Patient Confidence

Winning the Consumer Choice Award for six consecutive years reflects not only clinical excellence but also the confidence and loyalty of the Calgary community. The award is based on independent research that evaluates brand reputation, consumer satisfaction, and business performance in local markets. For Calgary Integrative Medicine, this recognition is a powerful reminder of the trust patients place in its doctors and staff.

“We are truly honoured to receive this recognition again,” adds Dr. Sikorski. “The feedback and trust of our patients inspire us to continue raising the standard of care. This acknowledgement motivates our entire team to keep innovating and providing therapies that genuinely improve people’s lives.”

Building Lasting Relationships with Patients

Calgary Integrative Medicine’s success stems from its patient-focused philosophy. Rather than offering one-size-fits-all solutions, practitioners take the time to understand each individual’s health history, lifestyle, and goals. By building strong relationships and focusing on root causes, the clinic helps patients achieve lasting results.

This approach resonates with Calgarians who are seeking more than conventional treatments alone. With its emphasis on whole-person health, Calgary Integrative Medicine continues to attract individuals from across Southern Alberta who are eager to explore natural, integrative healthcare.

A Trusted Wellness Partner for Calgary

Beyond clinical services, the clinic is dedicated to promoting wellness across the community. By raising awareness about the benefits of naturopathic medicine and encouraging preventative health practices, Calgary Integrative Medicine plays a key role in shaping healthier lifestyles. Its growth and ongoing recognition are a testament to its positive impact on both patients and the wider community.

As healthcare continues to evolve, the clinic remains committed to advancing its services while staying true to its core values of compassion, integrity, and personalisation. With a team of dedicated naturopathic doctors and a proven track record of patient satisfaction, Calgary Integrative Medicine is well-positioned to continue leading the way in natural and integrative healthcare in Southern Alberta.

To learn more about Calgary Integrative Medicine or to book an appointment, visit www.calgaryintegrativemedicine.ca or CLICK HERE.

About Calgary Integrative Medicine
Founded in 2017, Calgary Integrative Medicine is a leading naturopathic clinic in Calgary, Alberta. Specialising in chronic disease, digestive health, pain management, healthy ageing, and cancer care support, the clinic combines traditional and innovative therapies to promote lasting health. Services include IV nutritional therapy, acupuncture, herbal medicine, injection therapies, and manual osteopathy. With a focus on personalised care, Calgary Integrative Medicine empowers patients to restore balance and achieve long-term wellness. Learn more at www.calgaryintegrativemedicine.ca.

About Consumer Choice Award
Since 1987, Consumer Choice Award has been recognising and promoting business excellence across North America. Through a rigorous selection process, only the most outstanding businesses in each category earn this prestigious recognition. Learn more at www.ccaward.com.

Contact Information
Sumi Saleh
Communications Manager
ssaleh@ccaward.com

SOURCE: Consumer Choice Award

View the original press release on ACCESS Newswire